View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
June 8, 2020

Ventilators market to reach $5.2B during Covid-19 pandemic

The ventilators market is growing exponentially during the pandemic, due to its application to treat patients with severe Covid-19. According to GlobalData analysis, prior to the Covid-19 pandemic, the global ventilators market was valued at $1.1B in 2019, growing at an annual rate of 3.5%.

By GlobalData Healthcare

The ventilators market is growing exponentially during the pandemic, due to its application to treat patients with severe Covid-19. According to GlobalData analysis, prior to the Covid-19 pandemic, the global ventilators market was valued at $1.1B in 2019, growing at an annual rate of 3.5%. GlobalData expects the market to reach $5.2B in 2020, with a gradual decrease in growth of sales in coming years due to its load purchasing in 2020.

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Covid-19 has led to a surge in demand for ventilators that ventilator manufacturers cannot meet from existing inventory and that outstrips normal production rates. All ventilator manufacturers have full order books and hold little in stock, receiving orders not only from regular customers like hospitals, but also directly from governments. The companies aim to at least double their capacity in 2020.

To meet the demand, the manufacture of ventilators during Covid-19 relies on partnerships between medical manufacturers and companies that can provide additional production capacity. To date, the most successful partnerships are between existing ventilator manufacturers and large engineering companies, through expansion of manufacturing scale for existing or lightly modified versions of existing approved ventilators.

Many regulatory authorities accelerated the approval process for emergency ventilators. The FDA has waived the submission of premarket notification of modified ventilators in the US where the modification will not give rise to an undue concern, and allows alternative devices capable of delivering breath or pressure support during the Covid-19 pandemic.

The majority of the prototypes built for the pandemic are portable transport ventilators. Most devices had received regulatory approval prior to the outbreak. They offer critical care patient support for all age groups. Some are pneumatically powered and have no need for batteries or electrical power, making them suitable for transport or makeshift spaces. Some emergency ventilators tailored for Covid-19 patients only meet the minimally clinically acceptable standards, and they are only intended to last three to four months.

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU